Screener
Celldex Therapeutics CLDX Business Segments — Product Development Expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Celldex Therapeutics in its filing.
Tagged under the XBRL concept cldx:ProductDevelopmentExpenses.
The source filing: Celldex Therapeutics’s 10-K, filed February 25, 2026.
- Filed
- Feb 25, 2026, 4:06 PM EST
- Fiscal year
- FY2025
- Accession
- 0001104659-26-019652
| Line item | Year Ended / December 31, 2025 | Year Ended / December 31, 2024 | Year Ended / December 31, 2023 |
|---|---|---|---|
| Personnel | $57,204 | $51,906 | $40,121 |
| Laboratory Supplies | 5,997 | 5,611 | 5,358 |
| Facility | 5,301 | 5,094 | 4,970 |
| Product Development (b) | 161,096 | 90,604 | 59,319 |
| Other Expenses (c) | 15,476 | 10,335 | 8,243 |
| Total R&D Expense | $245,074 | $163,550 | $118,011 |
Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
FAQ
- What is Celldex Therapeutics's business segments — product development expenses?
- Celldex Therapeutics (CLDX) reported business segments — product development expenses of $40.27M in Q4 2025.
- How has Celldex Therapeutics's business segments — product development expenses changed year-over-year?
- Celldex Therapeutics's business segments — product development expenses increased by 77.8% year-over-year, from $22.65M to $40.27M.
- What is the long-term trend for Celldex Therapeutics's business segments — product development expenses?
- Over 3 years (2022 to 2025), Celldex Therapeutics's business segments — product development expenses has grown at a 71.1% compound annual growth rate (CAGR), from $32.16M to $161.1M.
- What does business segments — product development expenses mean?
- This metric quantifies the direct financial resources dedicated to the clinical advancement and technical development of the company's pipeline assets. It highlights the company's focus on translating scientific research into viable therapeutic products. Investors use this to gauge the intensity and pace of the company's clinical trial activities.
Ask your AI about Celldex Therapeutics's business segments — product development expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude